JGLYX
Price
$18.92
Change
-$0.39 (-2.02%)
Updated
Feb 3 closing price
Net Assets
2.48B
VEXRX
Price
$111.06
Change
-$1.83 (-1.62%)
Updated
Feb 3 closing price
Net Assets
20.23B
Interact to see
Advertisement

JGLYX vs VEXRX

Header iconJGLYX vs VEXRX Comparison
Open Charts JGLYX vs VEXRXBanner chart's image
JPMorgan Small Cap Growth R4
Price$18.92
Change-$0.39 (-2.02%)
VolumeN/A
Net Assets2.48B
Vanguard Explorer Adm
Price$111.06
Change-$1.83 (-1.62%)
VolumeN/A
Net Assets20.23B
JGLYX vs VEXRX Comparison Chart in %
View a ticker or compare two or three
VS
JGLYX vs. VEXRX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JGLYX is a StrongBuy and VEXRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 20.2B vs. JGLYX (2.48B). VEXRX pays higher dividends than JGLYX: VEXRX (0.54) vs JGLYX (0.17). JGLYX was incepted earlier than VEXRX: JGLYX (9 years) vs VEXRX (24 years). JGLYX (1.00) is less costly to investors than VEXRX (0.33). VEXRX is a more actively managed with annual turnover of: 51.00 vs. JGLYX (48.00). JGLYX has a lower initial minimum investment than VEXRX: JGLYX (0) vs VEXRX (50000). VEXRX annual gain was more profitable for investors over the last year : 0.66 vs. JGLYX (0.57). VEXRX return over 5 years is better than : -12.97 vs. JGLYX (-31.10).
JGLYXVEXRXJGLYX / VEXRX
Total Expense Ratio0.990.33300%
Annual Report Gross Expense Ratio1.000.33303%
Fund Existence9 years24 years-
Gain YTD5.5804.096136%
Front LoadN/AN/A-
Min. Initial Investment050000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.48B20.2B12%
Annual Yield % from dividends0.170.5432%
Returns for 1 year0.570.6686%
Returns for 3 years18.7713.57138%
Returns for 5 years-31.10-12.97240%
Returns for 10 yearsN/A72.29-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIVRX35.940.48
+1.35%
Thornburg International Equity R5
CVMRX25.310.28
+1.12%
Calvert Emerging Markets Equity R6
MBXBF0.16N/A
N/A
Microbix Biosystems Inc.
FRACF2.14N/A
N/A
Foraco International, Marseille
BRWUX27.17-0.51
-1.84%
MFS Blended Research Growth Eq R4